Prescription drug · NDA
Duvyzat (Givinostat) NDC 11797-110
Givinostat 8.86 mg/mL · Suspension · Oral · Italfarmaco SPA
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 11797-110-02 | 11797011002 | 1 BOTTLE in 1 CARTON (11797-110-02) / 140 mL in 1 BOTTLE (11797-110-01)Marketed from Mar 21, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Duvyzat
- Generic name (nonproprietary)
- givinostat
- Active ingredients
- Givinostat — 8.86 mg/mL
- Dosage form
- Suspension
- Route
- Oral
- Labeler
- Italfarmaco SPANDC labeler code 11797
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 217865
- Marketing start
- Listing expires
- Other FDA classes
- Cytochrome P450 3A4 Inhibitors (Mechanism)Histone Deacetylase Inhibitors (Mechanism)Organic Cation Transporter 2 Inhibitors (Mechanism)
- Identifiers
- Product ID 11797-110_23b3f0a7-bf0e-4221-a534-145f6c4ea8b7SPL ID 23b3f0a7-bf0e-4221-a534-145f6c4ea8b7SPL set ID 1a28a3db-7880-4ac2-a2f2-2b4e362aafb6RxCUI 2678894, 2678900UNII 5P60F84FBHUPC 0311797110019
- Pharmacologic class
- Histone Deacetylase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N411797011002followed by a unit qualifier and the quantityPackage 11797-0110-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
DUVYZAT is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older. DUVYZAT is a histone deacetylase inhibitor indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 11797-110
- What is NDC 11797-110?
- 11797-110 is the product NDC for Duvyzat (givinostat), Givinostat 8.86 mg/mL suspension, listed with the FDA by Italfarmaco SPA. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Duvyzat (Givinostat).
- What is the active ingredient?
- Givinostat.
- Who is the labeler?
- Italfarmaco SPA, NDC labeler code 11797. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Duvyzat?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.